Medicare Program; Request for Nominations for Members for the Medicare Evidence Development & Coverage Advisory Committee, 50110-50112 [2012-20298]
Download as PDF
50110
Federal Register / Vol. 77, No. 161 / Monday, August 20, 2012 / Notices
CHART 1—FINAL QUALIFYING INDIVIDUALS ALLOTMENTS FOR OCTOBER 1, 2010 THROUGH SEPTEMBER 30, 2011—
Continued
Initial QI allotments for FY 2011
State
Number of
individuals/3
(000s)
Percentage
of total
Col B/Tot.
Col B
A
B
C
FY 2011
Estimated QI
expenditures/1
Need
(difference)
If E>D,
E¥D
Percentage
of total need
states
F/(Tot. of F)
E
Initial QI
allotment
Col ×
$885,000,000
F
G
D
Reduction
pool for
non-need
States
If D>=E,
D¥E
Percentage
of total nonneed States
H/(Tot. of H)
H
I
Reduction
adjustment
for nonneed States
Col. 1 ×
$35,415,135
Increase adjustment for
need States
Col. G ×
$35,415,135
J
K
Final FY
2011 QI
allotment/2
L
California .........................
Colorado ..........................
Connecticut .....................
Delaware .........................
District of Columbia .........
Florida .............................
Georgia ...........................
Hawaii .............................
Idaho ...............................
Illinois ..............................
Indiana ............................
Iowa .................................
Kansas ............................
Kentucky .........................
Louisiana .........................
Maine ..............................
Maryland .........................
Massachusetts ................
Michigan ..........................
Minnesota ........................
Mississippi .......................
Missouri ...........................
Montana ..........................
Nebraska .........................
Nevada ............................
New Hampshire ..............
New Jersey .....................
New Mexico ....................
New York ........................
North Carolina .................
North Dakota ...................
Ohio .................................
Oklahoma ........................
Oregon ............................
Pennsylvania ...................
Rhode Island ...................
South Carolina ................
South Dakota ..................
Tennessee ......................
Texas ..............................
Utah .................................
Vermont ...........................
Virginia ............................
Washington .....................
West Virginia ...................
Wisconsin ........................
Wyoming .........................
103
18
19
6
3
106
41
4
6
65
37
21
17
27
30
5
17
35
47
22
17
34
6
7
9
6
29
12
88
51
3
69
17
19
72
6
24
4
34
117
9
2
33
21
15
32
2
7.09
1.24
1.31
0.41
0.21
7.30
2.82
0.28
0.41
4.47
2.55
1.45
1.17
1.86
2.06
0.34
1.17
2.41
3.23
1.51
1.17
2.34
0.41
0.48
0.62
0.41
2.00
0.83
6.06
3.51
0.21
4.75
1.17
1.31
4.96
0.41
1.65
0.28
2.34
8.05
0.62
0.14
2.27
1.45
1.03
2.20
0.14
62,735,719
10,963,524
11,572,608
3,654,508
1,827,254
64,562,973
24,972,471
2,436,339
3,654,508
39,590,502
22,536,132
12,790,778
10,354,439
16,445,286
18,272,540
3,045,423
10,354,439
21,317,963
28,626,979
13,399,862
10,354,439
20,708,878
3,654,508
4,263,593
5,481,762
3,654,508
17,663,455
7,309,016
53,599,449
31,063,317
1,827,254
42,026,841
10,354,439
11,572,608
43,854,095
3,654,508
14,618,032
2,436,339
20,708,878
71,262,904
5,481,762
1,218,169
20,099,794
12,790,778
9,136,270
19,490,709
1,218,169
28,587,784
5,295,566
4,486,600
3,146,625
0
66,436,364
26,906,212
1,291,051
2,343,040
24,682,083
7,442,661
4,271,524
4,610,144
15,690,958
20,326,470
5,682,148
7,088,750
10,537,185
15,085,628
6,222,133
15,159,850
5,920,121
1,621,995
2,506,235
4,524,038
2,135,209
10,947,452
4,380,182
46,599,154
29,879,017
732,156
23,482,476
10,487,929
13,141,294
33,758,390
2,322,853
15,020,561
1,720,053
26,632,392
78,314,925
2,259,983
3,698,518
12,026,439
9,678,240
6,570,617
5,065,273
885,008
NA
NA
NA
NA
NA
1,873,391
1,933,741
NA
NA
NA
NA
NA
NA
NA
2,053,930
2,636,725
NA
NA
NA
NA
4,805,411
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
133,490
1,568,686
NA
NA
402,529
NA
5,923,514
7,052,021
NA
2,480,349
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
5.2898
5.4602
NA
NA
NA
NA
NA
NA
NA
5.7996
7.4452
NA
NA
NA
NA
13.5688
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
0.3769
4.4294
NA
NA
1.1366
NA
16.7259
19.9124
NA
7.0036
NA
NA
NA
NA
NA
34,147,935
5,667,958
7,086,008
507,883
1,827,254
Need
Need
1,145,288
1,311,468
14,908,419
15,093,471
8,519,254
5,744,295
754,328
Need
Need
3,265,689
10,780,778
13,541,351
7,177,729
Need
14,788,757
2,032,513
1,757,358
957,724
1,519,299
6,716,003
2,928,834
7,000,295
1,184,300
1,095,098
18,544,365
Need
Need
10,095,705
1,331,655
Need
716,286
Need
Need
3,221,779
Need
8,073,355
3,112,538
2,565,653
14,425,436
333,161
14.2790
2.3701
2.9630
0.2124
0.7641
Need
Need
0.4789
0.5484
6.2340
6.3113
3.5623
2.4020
0.3154
Need
Need
1.3656
4.5080
5.6623
3.0014
Need
6.1839
0.8499
0.7348
0.4005
0.6353
2.8083
1.2247
2.9272
0.4952
0.4579
7.7543
Need
Need
4.2215
0.5568
Need
0.2995
Need
Need
1.3472
Need
3.3759
1.3015
1.0728
6.0320
0.1393
5,056,924
839,361
1,049,358
75,212
270,596
Need
Need
169,604
194,214
2,207,769
2,235,173
1,261,605
850,665
111,707
Need
Need
483,612
1,596,512
2,005,321
1,062,941
Need
2,190,048
300,992
260,245
141,828
224,991
994,564
433,727
1,036,665
175,382
162,172
2,746,211
Need
Need
1,495,060
197,203
Need
106,074
Need
Need
477,109
Need
1,195,573
460,932
379,944
2,136,244
49,337
NA
NA
NA
NA
NA
1,873,391
1,933,741
NA
NA
NA
NA
NA
NA
NA
2,053,930
2,636,725
NA
NA
NA
NA
4,805,411
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
133,490
1,568,686
NA
NA
402,529
NA
5,923,514
7,052,021
NA
2,480,349
NA
NA
NA
NA
NA
57,678,794
10,124,163
10,523,250
3,579,296
1,556,658
66,436,364
26,906,212
2,266,734
3,460,294
37,382,734
20,300,959
11,529,172
9,503,774
16,333,578
20,326,470
5,682,148
9,870,827
19,721,451
26,621,657
12,336,922
15,159,850
18,518,830
3,353,516
4,003,348
5,339,934
3,429,517
16,668,891
6,875,289
52,562,785
30,887,936
1,665,082
39,280,629
10,487,929
13,141,294
42,359,035
3,457,305
15,020,561
2,330,265
26,632,392
78,314,925
5,004,653
3,698,518
18,904,221
12,329,846
8,756,326
17,354,465
1,168,832
Total .........................
1,453
100.00
885,000,000
681,267,040
35,415,135
100.0000
239,148,095
100.0000
35,415,135
35,415,135
885,000,000
Footnotes:
1 FY 2011 Estimates from July 2011 CMS Survey of States.
2 For Need States, Final FY 2011 QI Allotment is equal to Initial QI Allotment in Column D increased by amount in Column K. For Non-Need States, Final FY 2011 QI Allotment is equal to Initial QI Allotment in Column D reduced by amount in Column J.
3 Three-year average (2007–2009) of number (000) of Medicare beneficiaries in State who are not enrolled in Medicaid but whose incomes are at least 120% but less than 135% of Federal
poverty level. Source: Census Bureau Annual Social and Economic Supplement (ASEC) to the 2010 Current Population Survey (CPS).
Authority: (Catalog of Federal Domestic
Assistance Program No. 93.778, Medical
Assistance Program).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: August 14, 2012.
Jennifer Cannistra,
Executive Secretary to the Department.
Centers for Medicare & Medicaid
Services
[FR Doc. 2012–20296 Filed 8–17–12; 8:45 am]
mstockstill on DSK4VPTVN1PROD with NOTICES
BILLING CODE 4120–01–P
[CMS–3273–N]
Medicare Program; Request for
Nominations for Members for the
Medicare Evidence Development &
Coverage Advisory Committee
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
This notice announces the
request for nominations for membership
on the Medicare Evidence Development
& Coverage Advisory Committee
SUMMARY:
VerDate Mar<15>2010
18:24 Aug 17, 2012
Jkt 226001
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
(MEDCAC). Among other duties, the
MEDCAC provides advice and guidance
to the Secretary of the Department of
Health and Human Services (the
Secretary) and the Administrator of the
Centers for Medicare & Medicaid
Services (CMS) concerning the
adequacy of scientific evidence
available to CMS for ‘‘reasonable and
necessary’’ determinations under
Medicare.
We are requesting nominations for
both voting and nonvoting members to
serve on the MEDCAC. Nominees are
selected based upon their individual
qualifications and not as representatives
of professional associations or societies.
We wish to ensure adequate
representation of the interests of both
E:\FR\FM\20AUN1.SGM
20AUN1
Federal Register / Vol. 77, No. 161 / Monday, August 20, 2012 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
women and men, members of all ethnic
groups and physically challenged
individuals. Therefore, we encourage
nominations of qualified candidates
who can represent these interests.
The MEDCAC reviews and evaluates
medical literature, technology
assessments, and hears public testimony
on the evidence available to address the
impact of medical items and services on
health outcomes of Medicare
beneficiaries.
DATES: Nominations must be received
by Monday, September 24, 2012.
ADDRESSES: You may mail nominations
for membership to the following
address: Centers for Medicare &
Medicaid Services, Center for Clinical
Standards and Quality, Attention: Maria
Ellis, 7500 Security Boulevard, Mail
Stop: South Building 3–02–01,
Baltimore, MD 21244.
FOR FURTHER INFORMATION CONTACT:
Maria Ellis, Executive Secretary for the
MEDCAC, Centers for Medicare &
Medicaid Services, Center for Clinical
Standards and Quality, Coverage and
Analysis Group, S3–02–01, 7500
Security Boulevard, Baltimore, MD
21244 or contact Ms. Ellis by phone
(410–786–0309) or via email at
Maria.Ellis@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
The Secretary signed the initial
charter for the Medicare Coverage
Advisory Committee (MCAC) on
November 24, 1998. A notice in the
Federal Register (63 FR 68780)
announcing establishment of the MCAC
was published on December 14, 1998.
The MCAC name was updated to more
accurately reflect the purpose of the
committee and on January 26, 2007, the
Secretary published a notice in the
Federal Register (72 FR 3853),
announcing that the Committee’s name
changed to the Medicare Evidence
Development & Coverage Advisory
Committee (MEDCAC). The charter for
the committee was renewed by the
Secretary on November 24, 2010. The
current charter is effective for 2 years.
The MEDCAC is governed by
provisions of the Federal Advisory
Committee Act, Public Law 92–463, as
amended (5 U.S.C. App. 2), which sets
forth standards for the formulation and
use of advisory committees, and is
authorized by section 222 of the Public
Health Service Act as amended (42
U.S.C. 217A).
The MEDCAC consists of a pool of
100 appointed members including: 94
voting members of whom 6 are
designated patient advocates, and 6
nonvoting representatives of industry
VerDate Mar<15>2010
16:25 Aug 17, 2012
Jkt 226001
interests. Members generally are
recognized authorities in clinical
medicine including subspecialties,
administrative medicine, public health,
biological and physical sciences,
epidemiology and biostatistics, clinical
trial design, health care data
management and analysis, patient
advocacy, health care economics,
medical ethics or other relevant
professions.
The MEDCAC works from an agenda
provided by the Designated Federal
Official. The MEDCAC reviews and
evaluates medical literature, technology
assessments, and hears public testimony
on the evidence available to address the
impact of medical items and services on
health outcomes of Medicare
beneficiaries. The MEDCAC may also
advise CMS as part of Medicare’s
‘‘coverage with evidence development’’
initiative.
II. Provisions of the Notice
As of January 2013, there will be 42
membership terms expiring. Of the 42
memberships expiring, 3 are nonvoting
industry representative and the
remaining 39 membership openings are
for the general MEDCAC voting
membership.
Accordingly, we are requesting
nominations for both voting and
nonvoting members to serve on the
MEDCAC. Nominees are selected based
upon their individual qualifications and
not as representatives of professional
associations or societies. We wish to
ensure adequate representation of the
interests of both women and men,
members of all ethnic groups and
physically challenged individuals.
Therefore, we encourage nominations of
qualified candidates from these groups.
All nominations must be
accompanied by curricula vitae.
Nomination packages must be sent to
Maria Ellis at the address listed in the
ADDRESSES section of this notice.
Nominees for voting membership must
also have expertise and experience in
one or more of the following fields:
• Clinical medicine including
subspecialties
• Administrative medicine
• Public health
• Biological and physical sciences
• Epidemiology and biostatistics
• Clinical trial design
• Health care data management and
analysis
• Patient advocacy
• Health care economics
• Medical ethics
• Other relevant professions
We are looking for experts in a
number of fields. Our most critical
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
50111
needs are for experts in hematology;
genomics; Bayesian statistics; clinical
epidemiology; clinical trial
methodology; knee, hip, and other joint
replacement surgery; ophthalmology;
psychopharmacology; rheumatology;
screening and diagnostic testing
analysis; and vascular surgery. We also
need experts in biostatistics in clinical
settings, cardiovascular epidemiology,
dementia, endocrinology, geriatrics,
gynecology, minority health,
observational research design, stroke
epidemiology, and women’s health.
The nomination letter must include a
statement that the nominee is willing to
serve as a member of the MEDCAC and
appears to have no conflict of interest
that would preclude membership. We
are requesting that all curricula vitae
include the following:
•
•
•
•
•
•
•
•
•
Date of birth
Place of birth
Social security number
Title and current position
Professional affiliation
Home and business address
Telephone and fax numbers
Email address
List of areas of expertise
In the nomination letter, we are
requesting that the nominee specify
whether they are applying for a voting
patient advocate position, for another
voting position or a nonvoting industry
representative. Potential candidates will
be asked to provide detailed information
concerning such matters as financial
holdings, consultancies, and research
grants or contracts in order to permit
evaluation of possible sources of
conflict of interest.
Members are invited to serve for
overlapping 2-year terms. A member
may serve after the expiration of the
member’s term until a successor is
named. Any interested person may
nominate one or more qualified persons.
Self-nominations are also accepted.
The current Secretary’s Charter for the
MEDCAC is available on the CMS Web
site at: https://www.cms.hhs.gov/FACA/
Downloads/medcaccharter.pdf, or you
may obtain a copy of the charter by
submitting a request to the contact listed
in the FOR FURTHER INFORMATION
CONTACT section of this notice.
Authority: 5 U.S.C. App. 2, section 10(a)(1)
and (a)(2).
(Catalog of Federal Domestic Assistance
Program No. 93.773, Medicare—Hospital
Insurance; and Program No. 93.774,
Medicare—Supplementary Medical
Insurance Program.)
E:\FR\FM\20AUN1.SGM
20AUN1
50112
Federal Register / Vol. 77, No. 161 / Monday, August 20, 2012 / Notices
Dated: August 8, 2012.
Patrick Conway,
CMS Chief Medical Officer and Director,
Center for Clinical Standards and Quality,
Centers for Medicare & Medicaid Services.
[FR Doc. 2012–20298 Filed 8–17–12; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Uniform Project Description
(UPD) Program Narrative Format for
Discretionary Grant Application Forms.
OMB No.: 0970–0139.
Description: The proposed
information collection would renew the
Administration for Children and
Families (ACF) Uniform Project
Description (UPD). The UPD provides a
uniform grant application format for
applicants to submit project information
in response to ACF discretionary
funding opportunity announcements.
ACF uses this information, along with
other OMB-approved information
collections (Standard Forms), to
evaluate and rank applications. Use of
the UPD helps to protect the integrity of
ACF’s award selection process. All ACF
discretionary grant programs are
required to use this application format.
The application consists of general
information and instructions; the
Standard Form 424 series, which
requests basic information, budget
information, and assurances; the Project
Description that requests the applicant
to describe how program objectives will
be achieved; and other assurances and
certifications. Guidance for the content
of information requested in the Project
Description is found in OMB Circular
A–102; 2 CFR, Part 215; 2 CFR, Part 225;
2 CFR, Part 230; 45 CFR, Part 74; and
45 CFR, Part 92.
Respondents: Applicants to ACF
Discretionary Funding Opportunity
Announcements.
ANNUAL BURDEN ESTIMATES
Number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
ACF Uniform Project Description (UPD) .........................................................
mstockstill on DSK4VPTVN1PROD with NOTICES
Instrument
5,205
1
60
312,300
Estimated Total Annual Burden
Hours: 312,300.
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Planning, Research and Evaluation, 370
L’Enfant Promenade SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. All requests should be
identified by the title of the information
collection. Email address:
infocollection@acf.hhs.gov.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Email:
OIRA_SUBMISSION@OMB.EOP.GOV,
Attn: Desk Officer for the
Administration for Children and
Families.
Robert Sargis,
Reports Clearance Officer.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Community Living
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request;
Developmental Disabilities Protection
and Advocacy Program Statement of
Goals and Priorities
Administration for Community
Living, HHS.
AGENCY:
ACTION:
Notice.
The Administration
Intellectual and Developmental
Disabilities (AIDD), Administration for
Community Living (ACL) is announcing
that the proposed collection of
information listed below has been
submitted to the Office of Management
and Budget (OMB) for review and
clearance under the Paperwork
Reduction Act of 1995.
SUMMARY:
Submit written comments on the
collection of information by September
19, 2012.
DATES:
Submit written comments
on the collection of information by fax
202.395.6974 to the OMB Desk Officer
for ACL, Office of Information and
Regulatory Affairs, OMB.
ADDRESSES:
[FR Doc. 2012–20326 Filed 8–17–12; 8:45 am]
FOR FURTHER INFORMATION CONTACT:
BILLING CODE 4184–01–P
Brianne Burger, 202.618.5525.
VerDate Mar<15>2010
16:25 Aug 17, 2012
Jkt 226001
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
In
compliance with 44 U.S.C. 3507, ACL
has submitted the following proposed
collection of information to OMB for
review and clearance. Federal statute
and regulation require each State
Protection and Advocacy (P&A) System
to prepare and solicit public comment
on a Statement of Goals and Priorities
(SGP) for the P&A for Developmental
Disabilities (PADD) program for each
coming fiscal year. While the P&A is
mandated to protect and advocate under
a range of different federally authorized
disabilities programs, only the PADD
program requires an SGP. Following the
required public input for the coming
fiscal year, the P&As submit the final
version of this SGP to the
Administration on Intellectual and
Developmental Disabilities (AIDD).
AIDD will aggregate the information in
the SGPs into a national profile of
programmatic emphasis for P&A
Systems in the coming year. This
aggregation will provide AIDD with a
tool for monitoring of the public input
requirement. Furthermore, it will
provide an overview of program
direction, and permit AIDD to track
accomplishments against goals/targets,
permitting the formulation of technical
assistance and compliance with the
Government Performance and Results
Act of 1993. ACL estimates the burden
of this collection of information as
follows:
SUPPLEMENTARY INFORMATION:
E:\FR\FM\20AUN1.SGM
20AUN1
Agencies
[Federal Register Volume 77, Number 161 (Monday, August 20, 2012)]
[Notices]
[Pages 50110-50112]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-20298]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3273-N]
Medicare Program; Request for Nominations for Members for the
Medicare Evidence Development & Coverage Advisory Committee
AGENCY: Centers for Medicare & Medicaid Services, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the request for nominations for
membership on the Medicare Evidence Development & Coverage Advisory
Committee (MEDCAC). Among other duties, the MEDCAC provides advice and
guidance to the Secretary of the Department of Health and Human
Services (the Secretary) and the Administrator of the Centers for
Medicare & Medicaid Services (CMS) concerning the adequacy of
scientific evidence available to CMS for ``reasonable and necessary''
determinations under Medicare.
We are requesting nominations for both voting and nonvoting members
to serve on the MEDCAC. Nominees are selected based upon their
individual qualifications and not as representatives of professional
associations or societies. We wish to ensure adequate representation of
the interests of both
[[Page 50111]]
women and men, members of all ethnic groups and physically challenged
individuals. Therefore, we encourage nominations of qualified
candidates who can represent these interests.
The MEDCAC reviews and evaluates medical literature, technology
assessments, and hears public testimony on the evidence available to
address the impact of medical items and services on health outcomes of
Medicare beneficiaries.
DATES: Nominations must be received by Monday, September 24, 2012.
ADDRESSES: You may mail nominations for membership to the following
address: Centers for Medicare & Medicaid Services, Center for Clinical
Standards and Quality, Attention: Maria Ellis, 7500 Security Boulevard,
Mail Stop: South Building 3-02-01, Baltimore, MD 21244.
FOR FURTHER INFORMATION CONTACT: Maria Ellis, Executive Secretary for
the MEDCAC, Centers for Medicare & Medicaid Services, Center for
Clinical Standards and Quality, Coverage and Analysis Group, S3-02-01,
7500 Security Boulevard, Baltimore, MD 21244 or contact Ms. Ellis by
phone (410-786-0309) or via email at Maria.Ellis@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
The Secretary signed the initial charter for the Medicare Coverage
Advisory Committee (MCAC) on November 24, 1998. A notice in the Federal
Register (63 FR 68780) announcing establishment of the MCAC was
published on December 14, 1998. The MCAC name was updated to more
accurately reflect the purpose of the committee and on January 26,
2007, the Secretary published a notice in the Federal Register (72 FR
3853), announcing that the Committee's name changed to the Medicare
Evidence Development & Coverage Advisory Committee (MEDCAC). The
charter for the committee was renewed by the Secretary on November 24,
2010. The current charter is effective for 2 years.
The MEDCAC is governed by provisions of the Federal Advisory
Committee Act, Public Law 92-463, as amended (5 U.S.C. App. 2), which
sets forth standards for the formulation and use of advisory
committees, and is authorized by section 222 of the Public Health
Service Act as amended (42 U.S.C. 217A).
The MEDCAC consists of a pool of 100 appointed members including:
94 voting members of whom 6 are designated patient advocates, and 6
nonvoting representatives of industry interests. Members generally are
recognized authorities in clinical medicine including subspecialties,
administrative medicine, public health, biological and physical
sciences, epidemiology and biostatistics, clinical trial design, health
care data management and analysis, patient advocacy, health care
economics, medical ethics or other relevant professions.
The MEDCAC works from an agenda provided by the Designated Federal
Official. The MEDCAC reviews and evaluates medical literature,
technology assessments, and hears public testimony on the evidence
available to address the impact of medical items and services on health
outcomes of Medicare beneficiaries. The MEDCAC may also advise CMS as
part of Medicare's ``coverage with evidence development'' initiative.
II. Provisions of the Notice
As of January 2013, there will be 42 membership terms expiring. Of
the 42 memberships expiring, 3 are nonvoting industry representative
and the remaining 39 membership openings are for the general MEDCAC
voting membership.
Accordingly, we are requesting nominations for both voting and
nonvoting members to serve on the MEDCAC. Nominees are selected based
upon their individual qualifications and not as representatives of
professional associations or societies. We wish to ensure adequate
representation of the interests of both women and men, members of all
ethnic groups and physically challenged individuals. Therefore, we
encourage nominations of qualified candidates from these groups.
All nominations must be accompanied by curricula vitae. Nomination
packages must be sent to Maria Ellis at the address listed in the
ADDRESSES section of this notice. Nominees for voting membership must
also have expertise and experience in one or more of the following
fields:
Clinical medicine including subspecialties
Administrative medicine
Public health
Biological and physical sciences
Epidemiology and biostatistics
Clinical trial design
Health care data management and analysis
Patient advocacy
Health care economics
Medical ethics
Other relevant professions
We are looking for experts in a number of fields. Our most critical
needs are for experts in hematology; genomics; Bayesian statistics;
clinical epidemiology; clinical trial methodology; knee, hip, and other
joint replacement surgery; ophthalmology; psychopharmacology;
rheumatology; screening and diagnostic testing analysis; and vascular
surgery. We also need experts in biostatistics in clinical settings,
cardiovascular epidemiology, dementia, endocrinology, geriatrics,
gynecology, minority health, observational research design, stroke
epidemiology, and women's health.
The nomination letter must include a statement that the nominee is
willing to serve as a member of the MEDCAC and appears to have no
conflict of interest that would preclude membership. We are requesting
that all curricula vitae include the following:
Date of birth
Place of birth
Social security number
Title and current position
Professional affiliation
Home and business address
Telephone and fax numbers
Email address
List of areas of expertise
In the nomination letter, we are requesting that the nominee specify
whether they are applying for a voting patient advocate position, for
another voting position or a nonvoting industry representative.
Potential candidates will be asked to provide detailed information
concerning such matters as financial holdings, consultancies, and
research grants or contracts in order to permit evaluation of possible
sources of conflict of interest.
Members are invited to serve for overlapping 2-year terms. A member
may serve after the expiration of the member's term until a successor
is named. Any interested person may nominate one or more qualified
persons. Self-nominations are also accepted.
The current Secretary's Charter for the MEDCAC is available on the
CMS Web site at: https://www.cms.hhs.gov/FACA/Downloads/medcaccharter.pdf, or you may obtain a copy of the charter by
submitting a request to the contact listed in the FOR FURTHER
INFORMATION CONTACT section of this notice.
Authority: 5 U.S.C. App. 2, section 10(a)(1) and (a)(2).
(Catalog of Federal Domestic Assistance Program No. 93.773,
Medicare--Hospital Insurance; and Program No. 93.774, Medicare--
Supplementary Medical Insurance Program.)
[[Page 50112]]
Dated: August 8, 2012.
Patrick Conway,
CMS Chief Medical Officer and Director, Center for Clinical Standards
and Quality, Centers for Medicare & Medicaid Services.
[FR Doc. 2012-20298 Filed 8-17-12; 8:45 am]
BILLING CODE 4120-01-P